SCHEMBL7302315

SCHEMBL7302315

Cc1[nH]cnc1CN1CCc2[nH]c3c(F)cccc3c2C1=O

nearest known ligand 0.56

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
ADRA2C P18825 1/20 0.56
HTR2A P28223 1/20 0.56
HTR2C P28335 1/20 0.56
ADRA1A P35348 1/20 0.56
HTR2B P41595 1/20 0.56
HTR3A P46098 1/20 0.56
KCNH2 Q12809 1/20 0.56
CASP6 P55212 1/20 0.56
CD44 P16070 2/20 0.39
P2RX7 Q99572 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Maleic Acid SCHEMBL7292838 0.93 CYP1A2 (0.50) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
Fumaric Acid SCHEMBL7292841 0.93 CYP1A2 (0.50) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
SCHEMBL10343 0.83 CYP1A2 (0.63) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
Maleic Acid SCHEMBL7296071 0.82 CYP1A2 (0.51) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
Fumaric Acid SCHEMBL7296076 0.82 CYP1A2 (0.51) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
Lurosetron SCHEMBL30949356 0.79 KCNH2 (0.72) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
Lurosetron SCHEMBL788289 0.79 KCNH2 (0.72) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
Lurosetron SCHEMBL7336906 0.78 KCNH2 (0.71) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
Lurosetron SCHEMBL7291773 0.78 CASP6 (0.72) CYP1A2CYP3A4ADRA2CHTR2AHTR2C
SCHEMBL7292887 0.78 CYP1A2 (0.36) CYP1A2CYP3A4ADRA2CHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0353983-B1 Lactam derivatives GLAXO GROUP LTD (GB) 1996-05-29 EP disclosed
US-5183820-A Useful for treatment of nausea, vomiting, irritable bowel syndrome and dyspepsia GLAXO GROUP LIMITED (GB) 1993-02-02 US disclosed